Susceptibility of human glial cells to infection with human immunodeficiency virus (HIV)
- PMID: 3549356
- DOI: 10.1016/0014-5793(87)81479-5
Susceptibility of human glial cells to infection with human immunodeficiency virus (HIV)
Abstract
Three human brain-derived cell lines (including two of astrocytic origin) were exposed in vitro to the human immunodeficiency virus (HIV), the etiologic agent of immunodeficiency in AIDS. In all three lines, HIV transcripts were detected by in situ hybridisation in 20-30% of cells 48 h after infection. Synthesis of virus gag gene products p24 and p55 was demonstrated by immunoblotting. No cytopathic effects typical of HIV-infected human T lymphocytes were observed. Our data indicate that HIV is neurotropic, and support the hypothesis that this virus may infect astrocytes in the brain.
Similar articles
-
Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV.J Virol. 1987 Dec;61(12):3774-82. doi: 10.1128/JVI.61.12.3774-3782.1987. J Virol. 1987. PMID: 2446007 Free PMC article.
-
Transient expression of human immunodeficiency virus type 1 genome results in a nonproductive infection in human fetal dorsal root ganglia glial cells.Virology. 1989 Dec;173(2):715-22. doi: 10.1016/0042-6822(89)90585-0. Virology. 1989. PMID: 2512746
-
Establishment of human glial cell lines chronically infected with the human immunodeficiency virus.Virology. 1988 Jan;162(1):151-9. doi: 10.1016/0042-6822(88)90404-7. Virology. 1988. PMID: 3336939
-
Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus.J Infect Dis. 1988 Mar;157(3):508-14. doi: 10.1093/infdis/157.3.508. J Infect Dis. 1988. PMID: 2830343
-
Cell surface effects of human immunodeficiency virus.Biosci Rep. 1988 Feb;8(1):35-48. doi: 10.1007/BF01128970. Biosci Rep. 1988. PMID: 3293665 Free PMC article. Review.
Cited by
-
Apolipoprotein E-dependent differences in innate immune responses of maturing human neuroepithelial progenitor cells exposed to HIV-1.J Neuroimmune Pharmacol. 2013 Sep;8(4):1010-26. doi: 10.1007/s11481-013-9478-0. Epub 2013 Jun 7. J Neuroimmune Pharmacol. 2013. PMID: 23744346
-
Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages.J Virol. 1991 Nov;65(11):5782-9. doi: 10.1128/JVI.65.11.5782-5789.1991. J Virol. 1991. PMID: 1920616 Free PMC article.
-
Characterization of Macrophage-Tropic HIV-1 Infection of Central Nervous System Cells and the Influence of Inflammation.J Virol. 2022 Sep 14;96(17):e0095722. doi: 10.1128/jvi.00957-22. Epub 2022 Aug 17. J Virol. 2022. PMID: 35975998 Free PMC article.
-
Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System.Curr Pharm Des. 2016;22(35):5477-5486. doi: 10.2174/1381612822666160726113001. Curr Pharm Des. 2016. PMID: 27464720 Free PMC article. Review.
-
Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent.J Virol. 1991 Feb;65(2):736-42. doi: 10.1128/JVI.65.2.736-742.1991. J Virol. 1991. PMID: 1702842 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources